Devyser Diagnostics AB (DVYSR) Stock Statistics & Valuation Metrics

Devyser Diagnostics AB has a market cap or net worth of kr1.03B. The enterprise value is kr1.41K.

Devyser Diagnostics AB has 16,653,658 shares outstanding. The number of shares has decreased by -2.65% in one year.

Devyser Diagnostics AB’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is 2.57%.

The current PE Ratio of Devyser Diagnostics AB is 69.8. Devyser Diagnostics AB’s PEG ratio is 2.59.

In the last 12 months, Devyser Diagnostics AB had revenue of 250.50M and earned -8.40M in profits. Earnings per share was -0.51.

In the last 12 months, operating cash flow was 36.00M and capital expenditures -31.10M, giving a free cash flow of 20.50M billion.

Devyser Diagnostics AB pays an annual dividend of ―, resulting in a dividend yield of ―

Devyser Diagnostics AB upcoming earnings date is Nov 3, 2026, Before Open (Confirmed).

Devyser Diagnostics AB as a current ratio of 2.88, with Debt / Equity ratio of 12.02%

In the past 12 months, Devyser Diagnostics AB has paid 5.80M in taxes.

Devyser Diagnostics AB EV to EBITDA ratio is 49.58, with an EV/FCF ratio of 279.00.

Devyser Diagnostics AB has kr81.00M in cash and marketable securities with kr45.80M in debt, giving a net cash position of kr35.20M billion.

Gross margin is 78.19%, with operating margin of 4.23%, and net profit margin of -3.35%.

The average price target for Devyser Diagnostics AB is ―, which is 11.43% higher than the current price. The consensus rating is ―